AI Article Synopsis

Article Abstract

Introduction: It is unknown how many days pass from the symptom onset to anticoagulation therapy of vein thrombosis (VT) in the leg in our country and whether this time has an impact on further development of the disease.

Methods: Among patients treated at our department in recent years for deep vein thrombosis in the leg, we selected 50 patients with the required data available. In each case the diagnosis was confirmed by duplex sonography. The mean age was 51 years and the group included 31 males and 19 females. Proximal VT was found in 72 % of the patients. Idiopathic VT was found in 38 % of the patients. The patients were followed for 3-6 months.

Results: The mean time to initiation of VT therapy was 10 days, range 1-42 days, median 7 days. Two thirds of the patients were treated with novel oral anticoagulants. Residual VT (incomplete recanalization) was present after 1-2 months of the therapy in 40.9 %, and after 3-6 months in 25 % of the patients. The positive relationship between the time to treatment and residual VT was significant both after 1-2 months of therapy (p < 0.05) and after 3-6 months of therapy (p < 0.01).

Conclusion: The time to VT treatment is clearly longer in our country compared to other countries. Delayed onset of treatment reduces the success rate of the therapy as assessed by an increased risk of residual thrombosis in the affected veins in subsequent months. Key words: delayed diagnosis - residual vein thrombosis - vein thrombosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

vein thrombosis
16
onset treatment
8
impact development
8
thrombosis leg
8
patients treated
8
1-2 months therapy
8
time treatment
8
therapy
6
patients
6
vein
5

Similar Publications

Background: This study aimed to provide a comprehensive review of adverse events (AEs) associated with factor Xa (FXa) inhibitors in pediatric patients.

Methods: We searched PubMed, Embase, Cochrane Library, ClinicalTrials.gov, and the European Union Clinical Trials Register for English-language records from the establishment of the database up to October 17, 2023.

View Article and Find Full Text PDF

Background: Deep vein thrombosis (DVT) of the lower limb is a significant clinical challenge with the potential for recurrence, which can lead to increased morbidity and reduced quality of life.

Methods: A retrospective case-control study was conducted involving 367 patients diagnosed with lower limb DVT from June 2020 to June 2023. Patients were categorized into a recurrence group ( = 121) and a non-recurrence group ( = 246) based on DVT occurrence.

View Article and Find Full Text PDF

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), continues to pose significant clinical challenges despite advancements in medical care. Artificial intelligence (AI) presents promising opportunities to enhance the diagnosis, prediction, and management of VTE. This review examines the transformative potential of AI in thrombosis care, highlighting both the potential benefits and the challenges that need to be addressed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!